miR-92b targets DAB2IP to promote EMT in bladder cancer migration and invasion
Author(s) -
Jun Huang,
Bin Wang,
Ke Hui,
Jin Zeng,
Jinhai Fan,
Xinyang Wang,
JerTsong Hsieh,
Dalin He,
Kaijie Wu
Publication year - 2016
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2016.4940
Subject(s) - oncogene , cancer research , microrna , epithelial–mesenchymal transition , suppressor , bladder cancer , cell cycle , metastasis , cancer , biomarker , molecular medicine , cell , cell migration , cell growth , biology , medicine , gene , biochemistry , genetics
Muscle-invasive or metastatic bladder cancer (BCa) has a very poor prognosis; however, its mechanisms remain largely unknown. Previous studies have discovered multiple microRNAs (miRs) that are involved in BCa progression and regarded as potential biomarkers or therapeutic targets. In this study, we demonstrated that miR-92b could uniquely promote cell migration and invasion of BCa cells, but had no effect on cell proliferation. Mechanistically, our data provided evidence to verify that miR-92b was able to directly target DAB2IP, a well-known tumor suppressor, and inhibit epithelial‑mesenchymal transition of BCa cells. Moreover, the increased expression levels of miR-92b were negatively correlated with DAB2IP, and predicted poor prognosis of patients with BCa. Overall, this study reveals a new promising biomarker and its mechanisms contributing to BCa invasion or metastasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom